| |
| |
|
| Insider
Information: |
Yordon Jeffrey |
| Relationship: |
See Remarks |
| City: |
Schaumburg |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
862,019 |
|
|
Indirect Shares
|
69,938 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
931,957 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sagent Pharmaceuticals Inc |
SGNT |
Director |
2015-02-27 |
616,076 |
2015-02-27 |
69,938 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
See Remarks |
2022-08-03 |
245,943 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2022-08-03 |
4 |
D |
$0.58 |
$2,127 |
D/D |
(3,663) |
245,943 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2022-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,500 |
249,606 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2020-09-10 |
4 |
OE |
$11.00 |
$199,980 |
D/D |
18,180 |
237,106 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2020-03-12 |
4 |
B |
$8.14 |
$81,430 |
D/D |
10,000 |
218,926 |
2.74 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,717 |
208,926 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2018-11-14 |
4 |
B |
$10.49 |
$99,655 |
D/D |
9,500 |
198,209 |
2.74 |
- |
|
| ATNX |
Athenex, Inc. |
See Remarks |
• – – |
2018-03-26 |
4 |
B |
$14.69 |
$73,450 |
D/D |
5,000 |
188,709 |
2.74 |
- |
|
| ATNX |
Athenex, Inc. |
See RemarksOfficer |
• – – |
2017-06-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
183,709 |
|
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Director |
– • – |
2015-02-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
48,850 |
616,076 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,945 |
686,014 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-02-22 |
4 |
D |
$28.50 |
$26,163 |
D/D |
(918) |
676,069 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-02-21 |
4 |
D |
$28.50 |
$34,970 |
D/D |
(1,227) |
676,987 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2015-02-18 |
4 |
D |
$27.22 |
$28,663 |
D/D |
(1,053) |
678,214 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2014-02-22 |
4 |
D |
$21.75 |
$20,771 |
D/D |
(955) |
679,267 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2014-02-21 |
4 |
D |
$21.84 |
$27,933 |
D/D |
(1,279) |
680,222 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
13,393 |
681,501 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2013-09-16 |
4 |
S |
$20.03 |
$1,718,680 |
D/D |
(85,813) |
669,036 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2013-02-22 |
4 |
D |
$16.85 |
$15,637 |
D/D |
(928) |
668,108 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2013-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,805 |
754,849 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2012-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
11,800 |
703,958 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2011-07-23 |
4 |
OE |
$4.31 |
$68,736 |
D/D |
15,948 |
739,044 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2011-06-01 |
4 |
OE |
$4.23 |
$80,954 |
D/D |
19,138 |
723,096 |
0 |
- |
|
| SGNT |
Sagent Pharmaceuticals In... |
Chief Executive OfficerOfficer |
• • – |
2011-04-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
692,158 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
